The Netherlands: Court rules on remedies for contributory infringement in Europe

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The Netherlands: Court rules on remedies for contributory infringement in Europe

A Dutch court issued decisions in two court actions that illustrate the remedies that are available from the Dutch courts in cases of contributory infringement. The court found that it had jurisdiction to issue a preliminary injunction on offering and supplying a contributorily infringing product inside and outside the Netherlands, also against a non-Dutch party. The patent acts throughout Europe were essentially identical on contributory infringement. However, the court held that patent law excluded an injunction on holding a contributorily infringing product in stock.

In Rasco v AEBI Schmidt (Court of The Hague, January 4 2017), Rasco supplied a detachable salt spreader for use on trucks to de-ice roads. AEBI Schmidt asserted that trucks with such a detachable salt spreader infringed its patent. The court found contributory infringement, because it considered the salt spreaders to be "essential components" in the sense of contributory infringement law, and ordered a recall. However, the court held that holding in stock of such essential components, which contributorily infringed but had not been patented themselves, was not prohibited by Dutch patent law: patent law only prohibited offering and supplying such products.

In DSM v Univar and Novozymes (Court of The Hague, January 6 2017), the patent claimed a process to produce a dairy product using a previously known lactase preparation. The Danish company Novozymes manufactured the lactase preparation. The Dutch company Univar was Novozymes' exclusive co-distributor for Europe. The Dutch court found that it has jurisdiction to issue a preliminary injunction inside and outside the Netherlands against Univar, because it was a Dutch company, and also against Novozymes, because the action concerned the same product. The product had a substantial non-infringing use, but evidence showed that Univar and Novozymes induced infringement. Accordingly, the injunction was limited to offering/supplying the lactase preparation for use in the patented invention.

Lars de Haas


V.O.Johan de Wittlaan 72517 JR The HagueThe NetherlandsTel: +31 70 416 67 11Fax: +31 70 416 67 99info@vo.euwww.vo.eu

more from across site and SHARED ros bottom lb

More from across our site

Nick Groombridge shares how an accidental turn into patent law informed his approach to building a practice based on flexibility and balancing client and practitioner needs
Clarivate’s Ed White discusses the joy of measuring innovation and why patent attorneys are a special breed
National groups for the UK and the Netherlands have flagged concerns with the choice of venue, following a formal complaint from Australia’s national group
Rasenberger is the CEO at the Authors Guild in the US
Vold-Burgess is the client director at Acapo Onsagers and the former CEO at Acapo in Norway
Williams is the CEO of the UKIPO in the UK
Orliuk is director of the Ukrainian IP office
Julie is chief IP counsel at Teva in the US
Ludlam is chief IP and litigation officer at Lenovo, while Maharaj is chief licensing officer for Ericsson in the US
Campinos is the president of the EPO in Munich
Gift this article